Eleven small and medium enterprises will benefit from a total of £2.2 million of funding from the Biotechnology and Biological Sciences Research Council under its Small Business Research Initiative. The firms are Critical Pharmaceuticals Ltd, Nottingham; Daniolabs, Cambridge; deltaDOT Ltd, London; Celltran Ltd, Sheffield; Farfield Sensors Ltd, Salford; Oxitec Ltd, Oxford; MedPharm Ltd, Charlbury, Oxfordshire; Lumora Ltd, Cambridge; Plasso Technology Ltd, Sheffield; Southampton PolyPeptides Ltd, Southampton; Zyentia Ltd, Cambridge.
Please
or to read this article.Register to continue
Get a month's unlimited access to THE content online. Just register and complete your career summary.
Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:
- Sign up for the editor's highlights
- Receive World University Rankings news first
- Get job alerts, shortlist jobs and save job searches
- Participate in reader discussions and post comments
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Subscribe
Already registered or a current subscriber?
